Kelly Lowery
Family · Valdosta, GANPI 1770149973
Payments from drug & device makers
Across 305 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$469
- Alkermes, Inc.$436
- Takeda Pharmaceuticals U.S.A., Inc.$397
- Axsome Therapeutics, Inc.$391
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$326
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,841100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$4,841 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 15 | $209,074 |
| VraylarCariprazine Hcl | 91 | $136,579 |
| RexultiBrexpiprazole | 43 | $65,421 |
| TrintellixVortioxetine Hydrobromide | 44 | $21,082 |
| Aripiprazole | 234 | $7,711 |
| Lurasidone Hcl | 44 | $6,839 |
| Bupropion XlBupropion Hcl | 380 | $5,659 |
| Imipramine Pamoate | 11 | $4,669 |
| Duloxetine Hcl | 215 | $3,468 |
| Atomoxetine Hcl | 28 | $3,188 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 53 | $3,181 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 184 | $2,794 |
| Ziprasidone Hcl | 50 | $2,641 |
| Sertraline Hcl | 274 | $2,396 |
| Trazodone Hcl | 297 | $2,272 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $274 | $209,07415 claims |
| AbbVieVraylar | $1,095 | $136,57991 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $469 | $65,42143 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $397 | $21,08244 claims |
| Almatica Pharma LLCSertraline Hcl | $54 | $2,396274 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Valdosta
- Shelby McNealValdosta$14K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.